▲ Peaking
Business
🔮 holds
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026
Eli Lilly shares surge following a CHMP recommendation for the EU approval of Jaypirca to treat chronic lymphocytic leukemia.